baber/WOPTO huggingface dataset:
Patent NZ-270468-A (NZ)
Title: Synergistic mild permanent wave composition for treating human hair: ionic complex of cationic and anionic compounds
Inventor: NEILL PAUL
IPC: A61K8/46
Filed: 1995-02-08
Abstract: A mild permanent wave reducing agent-containing composition includes two ionic compounds, one cationic and the other anionic, that complex in solution over a molar ratio of cationic compound to anionic compound in the range of 1:1.2 to 1.2:1. The cationic compound, in solution, forms a cation of formula I or formula II, or a mixture of two or more thereof; <CHEM>   <CHEM> wherein R1, R2, R3, R5, R6 and R7, same or different, are H, an alkyl group or hydroxyalkyl group having 1 to 5 carbon atoms; and R4 is OH, -OR8 or -NR9R10, wherein R8, R9 and R10, same or different, are H, an alkyl group or hydroxyalkyl group having 1 to 4 carbon atoms, A is an alkylene group having 1 to 5 carbon atoms; and B is O or S; and the anionic compound. in solution, forms an anion of formula III: <CHEM> wherein A is nonexistent or an alkylene group having 1 to 5 carbon atoms, and Y is H, OH, NH2 or <CHEM> wherein R12 is an alkyl group having 1 to 5 carbon atoms. Examples of cationic compounds include thiocholine, choline, cysteineamide, cysteamine, and combinations thereof. Examples of anionic compounds include cysteine, N-acetylcysteine, thioglycolic acid or its salts, and combinations thereof.
Patent NZ-276885-A (NZ)
Title: Substituted pyrazolyl-benzenesulphonamide derivatives, preparation and pharmaceutical compositions thereof
Inventor: TALLEY JOHN J
IPC: C07D231/10
Filed: 1994-11-14
Abstract: A class of pyrazolyl benzenesulfonamide compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula I:    <IMAGE>  (I)  or a pharmaceutically-acceptable salt thereof.
Patent NZ-286017-A (NZ)
Title: Polyunsaturated aliphatic fatty acid derivatives containing a 2,6,6-trimethylcyclohexene derivatives; etherified combination agent is e-3,7-dimethyl-9-[(2-methoxy-4-methyl-6-octyloxy)phenyl]-2,4,6, 8-nonatetraenoic acid
Inventor: KLAUS MICHAEL
IPC: C07C63/00
Filed: 1996-02-19
Abstract: Novel nonatetraenoic acid derivatives of the formula <CHEM> wherein the dotted bond is optional and R1 and R2 are as defined in the specific ation selectively bind to retinoic acid X-receptors (RXR) have anti-acne acitvity and potentiate the activity of retinoids having RAR alpha  activity.
Patent NZ-311044-A (NZ)
Title: Calcium carbonate filler for paper manufacture
Inventor: SILENIUS PETRI
IPC: D21H17/67
Filed: 1996-06-27
Abstract: The invention relates to a filler used in paper manufacture and mainly consisting of calcium carbonate, and to a procedure for producing the filler. The filler consists of porous aggregates formed by precipitated calcium carbonate particles. In the procedure, calcium carbonate is precipitated.
Patent NZ-314696-A (NZ)
Title: Flash flotation device, for extracting minerals from a slurry, comprising agitation means and aeration means
Inventor: BOURKE PETER
IPC: B03D1/14
Filed: 1997-04-29
Abstract: A flash flotation device (1) comprises a tank (2) to contain slurry (3) incorporating minerals to be extracted, a feed inlet (25) for admission of slurry (3) into the tank (2), agitation means (10) to agitate the slurry (3) within the tank (2), aeration means to aerate the slurry (3) whereby floatable minerals in suspension form a surface froth for removal via froth lip (29), a bottom outlet (26) for withdrawal of relatively coarse or dense components of the slurry (3) from the tank (2), and a side outlet (28) to regulate the level of slurry (3) in the tank (2).
Patent NZ-316026-A (NZ)
Title: A transdermal therapeutic system (a hormone patch) in which drugs are contained which are released into the skin comprising a backing film and a pressure sensitive adhesive
Inventor: CORDES GUNTER
IPC: A61K47/10
Filed: 1996-07-22
Abstract: A transdermal therapeutic system (TTS) which contains as the active ingredients an oestrogen and a gestagen or a gestagen or androgen as well as an acrylate adhesive and, as resorption promoters, the two substances oleic acid and 2-(2-ethoxyethoxy)ethanol.
Patent NZ-318183-A (NZ)
Title: Substituted benzothieno-substituted-benzopyrans and their use in lowering serum cholesterol levels
Inventor: GRESE TIMOTHY ALAN
IPC: C07D311/78
Filed: 1996-08-26
Abstract: The present invention relates to compounds of formula I and II; <CHEM>   <CHEM>  wherein     X is -O-, -S-, or -NR<5>-;   Y is -O-, -S-, -CH2-, -CH2CH2-, -CH=CH-, or -NR<5>-;   B is -CH<2>- or -CO-; R<1>, R<2>, and R<3> are each independently -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), -OSO2(C4-C6 alkyl), -OSO2CF3, Cl, or F;   n is 1 or 2;   W is CH2 or C=O; R<4> is 1-piperidinyl, 2-oxo-1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 2-oxo-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; R<5> is C1-C3 alkyl, -COC6H5, -CO(C1-C6 alkyl), -C(O)OC6H5, -C(O)O(C1-C6 alkyl), -SO2(C1-C6 alkyl), -SO2C6H5, or -SO2CF3;  or a pharmaceutically acceptable salt thereof. Also provided by the present invention are intermediate compounds; processes for the preparation of compounds of Formulae I and II; and pharmaceutical methods and formulations employing the compounds of Formulae I and II.
Patent NZ-319974-A (NZ)
Title: Mouthwash antimicrobial compositions containing a c3-c6 alcohol
Inventor: PAN PAULINE C
IPC: A61K8/49
Filed: 1996-10-10
Abstract: An antimicrobial composition containing an alcohol having 3 to 6 carbon atoms which effectively increases antimicrobial activity and particularly a mouthwash composition that is useful in the prevention and reduction of bad breath, plaque and related gum diseases having an antimicrobially effective amount of one or more active essential oils; from about 0.01 % to about 30.0 % v/v of an alcohol having 3 to 6 carbon atoms; optionally, ethanol; at least one surfactant; and water. The actives not only provide enhanced efficacy but are completely solubilized, thus providing an aesthetically appealing product.
Patent NZ-335156-A (NZ)
Title: Process for selective derivatization of taxanes by acylation of C(10)hydroxy group
Inventor: HOLTON ROBERT A
IPC: C07F7/18
Filed: 1998-08-17
Abstract: A process for the treatment of the C(10) hydroxy group to form a C(10) acylated taxane, or  a C(10) silylated taxane, or treatment of the C(7) hydroxy group to form a C(7) ketalized taxane, and taxanes prepared by these processes are disclosed. Particularly, the C(10) hydroxyl group is protected or derivatized prior to the C(7) hydroxyl group. To prepare acylated taxanes, a reaction mixture is formed that includes the taxane and an acylating agent, which contains less that one equivalent of a base for each equivalent of taxane. Similarly for C(10) silylated taxanes, silylamides or bissilylamides are used at a rate less than the amount of taxane. To form the ketalized taxane a ketalizing agent is used in the presence of an acid catalyst.
Patent NZ-336925-A (NZ)
Title: Selection method for transgenic plants
Inventor: DONALDSON IAIN ALASDAIR
IPC: C12N15/31
Filed: 1998-02-05
Abstract: A selection method for selecting from a population of cells one or more selectable genetically transformed cells is described. In the method, the population of cells comprises selectable genetically transformed cells and possible non-transformed cells. Each of the selectable genetically transformed cells comprises a first expressible nucleotide sequence and optionally a second expressible nucleotide sequence. In the method, a component or a metabolic derivative thereof when present in a low concentration in a medium is a nutrient for both the selectable genetically transformed cells and the non-transformed cells. In the method, the component or the metabolic derivative thereof when present in a high concentration in a medium is toxic to the non-transformed cells. The first nucleotide sequence codes for a gene product capable of converting the component or the metabolic derivative thereof when present in a high concentration in a medium to a nutrient for the selectable genetically transformed cells. The method comprises the step of introducing the population of cells to a medium, wherein the medium optionally comprises a high concentration of the component or the metabolic derivative thereof. In the method, the component or the metabolic derivative thereof is a source of both carbohydrate and nitrogen for the selectable genetically transformed cells. Alternatively, in the method if a portion of the component serves as a metabolic substrate and is metabolically converted to a substrate, then that substrate is capable of providing an allosteric effect on the gene product.
Patent NZ-337432-A (NZ)
Title: Applicator of abrasive material and water to roading or floors to remove surface material, e.g. excess bitumin
Inventor: JONES RHYS ALEXANDER
IPC: B24C9/00
Filed: 2000-03-10
Abstract: An abrasive applicator assembly 1, for removal of surface material from a work surface 6, includes a containment portion 2 to encompass an area of the work surface and at least one abrasive applicator nozzle 5a, 5b, directable towards work surface 6.  The nozzle is connected or connectable to means 22 for supplying and propelling both abrasive material and water therethrough.  The nozzle is capable of movement during use within a plane substantially parallel to the work surface by either or both of two methods: i) mounting the nozzle on a moveable portion allowing planar movement of the nozzle within the containment portion, and ii) connecting the assembly to a vehicle mounting in an arrangement causing the assembly to travel from side to side as a consequence of forward movement of the vehicle. At least one exhaust port 11 is included in the containment portion, connected or connectable to vacuum means for the withdrawal of air and other matter from within the containment portion.  The assembly further includes a pump for providing a pressured water supply to the nozzle and/or means for connection of the nozzle to a pressurised water supply.  Typical work surfaces include roading, paving and floors.  Typical surface materials include bitumin, paint and protective finishes.
Patent NZ-505140-A (NZ)
Title: A near infrared (NIR) wavelength film containing a tin oxide with a NIR dopant
Inventor: MCKOWN CLEM STEFFLER
IPC: C23C16/40
Filed: 1999-08-09
Abstract: The specification describes a NIR film comprising tin oxide containing a NIR dopant selected from antimony, tungsten, vanadium, iron, chromium, molybdenum, niobium, cobalt and nickel and containing a fluorine dopant at an atomic concentration less than the concentration of the NIR dopant.
Patent NZ-509393-A (NZ)
Title: Method of ultrasonic therapy using an apparatus including a gel containment structure
Inventor: RYABY JOHN P
IPC: A61B17/22
Filed: 1995-03-02
Abstract: A   method   of   treating  or  evaluating   internal musculoskeletal  injuries  by  ultrasound,   comprising   an ultrasound  generation  module  (18)  and  a  coupling   gel containment  structure (10) for placing on  or  adjacent  to the  operating  surface  (22) of the  ultrasound  generating module  and  against  the  external  location  on  the  skin corresponding  to  the  internal injury.  The  coupling  gel containment  structure  (10) directs ultrasound  waves  from the  operating  surface  (22) of the  ultrasound  generating part  through  the  enclosed coupling gel  to  the  external location   corresponding  to  the   internal   injury.   The containment  system (10) may be in the form  of  a  bladder, cap  or  pad which may be placed against or fitted upon  the operating surface of the ultrasound generating part so  that the operating surface is inside the containment structure.
Patent NZ-513201-A (NZ)
Title: Plant nutrient composition
Inventor: BELL PETER DARYL
IPC: A01G29/00
Filed: 2001-07-27
Abstract: A plant nutrient composition comprising a chromium-collagen complex anion exchanger loaded with phosphate anions. Preferably, the chromium-collagen complex anion exchanger is comminuted chrome-tanned leather derived from off-cut wastes from a chrome-tanning process.
Patent NZ-513290-A (NZ)
Title: Neutrokine-alpha and neutrokine-alpha splice variant
Inventor: ROSEN CRAIG A
IPC: C07K14/52
Filed: 2000-02-22
Abstract: Disclosed are isolated nucleic acid molecules comprising, or alternatively, consisting of, a polynucleotide encoding a cytokine and an apparent splice variant thereof that are structurally similar to TNF and related cytokines and have similar biological effects and activities. This cytokine is named Neutrokine-alpha and includes Neutrokine-alpha polypeptides having at least a portion of the amino acid sequence in Figures 1A and 1B (SEQ ID NO: 2) or amino acid sequence encoded by the cDNA clone (HNEDU15) deposited on October 22, 1996 assigned ATCC number 97768. The nucleotide sequence determined by sequencing the deposited Neutrokine-alpha clone, which is shown in Figures 1A and 1B (SEQ ID NO: 1), contains an open reading frame encoding a complete polypeptide of 285 amino acid residues including an N-terminal methionine, a predicted intracellular domain of about 46 amino acid residues, a predicted transmembrane domain of about 26 amino acids, a predicted extracellular domain of about 213 amino acids, and a deduced molecular weight for the complete protein of about 31 kDa. As for other type II transmembrane proteins, soluble forms of Neutrokine-alpha include all or a portion of the extracellular domain cleaved from the transmembrane domain and a polypeptide comprising the complete Neutrokine-alpha polypeptide lacking the transmembrane domain, i.e. the extracellular domain linked to the intracellular domain.
Patent NZ-514323-A (NZ)
Title: A immunostimulant containing an acitive agent and an adjuvant which increases the effect of the active agent
Inventor: ALPAR HAZIRE OYA
IPC: A61P31/12
Filed: 2000-03-23
Abstract: A   pharmaceutical  composition   comprises   (i)   a biologically  active  agent and (ii)  an  adjuvant  chemical that  increases the effect of the biologically active  agent and (iii) a pharmaceutically acceptable carrier or diluent. The  adjuvant is one or more of A) a polyamino  acid,  B)  a water  soluble vitamin or vitamin derivative, C)  positively charged  cationic pluronics, D) a clathrate, E) a complexing agent,  F) cetrimides; G) an S-layer protein; or H)  Methyl- glucamine provided  that  when  the adjuvant is D)  or  E),  then  the biologically  active agent is an agent which is  capable  of generating  a  protective immune response in  an  animal  to which it is administered or provided that when the adjuvant is A), then the biologically active  agent  is an agent which is capable of generating  a protective  immune  response in an animal  to  which  it  is administered,  the  composition  is  for  administration  to mucosal surfaces or provided that when the adjuvant is C), then the biologically active  agent  is an agent which is capable of generating  a protective  immune  response in an animal  to  which  it  is administered,  then  the  composition  does  not  contain  a polyacrylic acid or provided that when the adjuvant is G), then the biologically active  agent  is an agent which is capable of generating  a protective  immune  response in an animal  to  which  it  is administered,  the  carrier  or  diluent  of  (iii)   is   a microsphere or liposome.
Patent NZ-520353-A (NZ)
Title: Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative
Inventor: YOTSUYA SHUICHI
IPC: A61P1/04
Filed: 2001-01-30
Abstract: Remedies or preventives for digestive diseases which contain as the active ingredient diaminotrifluoromethylpyridine derivatives represented by the following general formula (I) or its salts are disclosed, wherein X represents CW1R1, -COCOR2, CW1NHCOR2, -C(=W1)W2R3 or -CW1N(R4)R5; and Y represents alkyl, -CW3R6, -COCOR7, -NHCOR7, -C(=W3)W4R8, -(NH)mSO2R9, -(NH)mSO2OR10 or -(NH)mSO2N(R11)R12 (wherein R1, R6 and R9 represent each chain hydrocarbyl, monocyclic hydrocarbyl, polycyclic hydrocarbyl, a monocyclic heterocycle or a polycyclic heterocycle; R2 and R7 represent each alkyl, alkoxy, phenyl or phenoxy; R3, R8 and R10 represent each alkyl, alkenyl, alkynyl, cycloalkyl, phenyl or benzyl; R4, R5, R11 and R12 represent each alkyl; W1, W2, W3 and W4 represent each oxygen or sulfur; and m is 0 or 1).
Patent NZ-523067-A (NZ)
Title: Locking device for a door with electromagnetic lock in conjunction with mechanical latches
Inventor: FLY DEREK
IPC: E05C19/16
Filed: 2001-06-28
Abstract: An electromagnetic lock (10) for a door is disclosed. The lock (10) includes a backing plate (12) which is connectable to a door frame, an electromagnet (14), a housing (30) for the electromagnet, and an armature plate (16) connectable to a door (32) which is displaceable relative to the housing (30) between a closed condition in which it engages the housing and an open condition in which it is spaced from the housing. The lock (10) also includes two locking arms (18) which are movable between an operative position in which they engage the armature plate (16) and the backing plate (12) to capture the armature plate in the closed condition and an inoperative position in which they allow the armature plate to disengage the housing (30).
Patent NZ-525038-A (NZ)
Title: Electrophoresis apparatus for simultaneous loading of multiple samples
Inventor: CABILLY SHMUEL
IPC: B03C5/00
Filed: 2001-08-29
Abstract: The wells 39 in an electrophoresis gel layer are arranged in a plurality of alternating staggered spaced apart rows, so that the wells of the odd rows are laterally offset by a predetermined distance XM in the same direction along the axes of the odd rows relative to the positions of the corresponding wells of the even rows along the axes of the even rows. Under the influence of the electrophoresis force the molecules can travel the distance 43 from a well before encountering an interfering well. Well loading plates with regular loading sites 38 on the top surface, apertures 39 leading to the wells on the bottom surface, and channels 40 between the loading sites and apertures can be used to load the well using standard multi-drop pipettes without having to oscillate the pipette from side to side to load the offset well rows.
Patent NZ-527051-A (NZ)
Title: 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
Inventor: ZHOU PING
IPC: A61P3/04
Filed: 2002-01-18
Abstract: Compounds of general formula I, their manufacture and uses to treat motor, anxiety, and cognitive disorders including schizophrenia, depression, Alzheimer's or Parkinson's disease. .
Patent NZ-529995-A (NZ)
Title: A wireless network for providing audio-visual content in a mobile environment to one or more passenger vehicles
Inventor: GORHAM NIGEL PETER
IPC: H04N7/173
Filed: 2003-12-05
Abstract: A system (10) for the provision of audiovisual material in a mobile environment such as for a bus or train comprises: a) a host computer apparatus (12) forming audiovisual programming data (14) from source material such as from television network and advertisers; b) a local area wireless network (16) to which the computer apparatus is connected for the distribution of a first type of programming data; c) a radio frequency transmitter (60) connected to the computer apparatus for the transmission of a second type of programming data and d) a plurality of vehicles (50n, 40n) each including: di) a local area wireless receiver to receive the first type of programming data; dii) a radio frequency transceiver for receiving the second type of programming data; diii) computer apparatus for processing the first type of programming data and any received second type of programming data to sequence passenger audiovisual programming; div)display means for displaying the video component of the passenger audiovisual programming and dv) wireless local area audio transmitter to broadcast the audio component of the passenger audiovisual programming.
Patent NZ-537163-A (NZ)
Title: A direct cellular energy delivery system
Inventor: EHRINGER WILLIAM D
IPC: A61K47/44
Filed: 2003-05-09
Abstract: Disclosed is a vesicle comprising: a phospholipid which is a stable vesicle former, and at least one member selected from the group consisting of another polar lipid which is not a stable vesicle former, PEG, a raft former, and a fusion protein; wherein the vesicle has a fusion rate of at least 20 vesicle fusions/second. Vesicles of the type described further containing ATP are particularly useful in the delivering of ATP to a cell and for treating wounds.
Patent NZ-541560-A (NZ)
Title: Swab for collecting biological specimens
Inventor: TRIVA DANIELE
IPC: A61M35/00
Filed: 2004-03-31
Abstract: A swab (20) for collecting biological specimens of the type consisting of a rod (14) terminating in a tip (16) covered with fibre (17) with hydrophilic properties to allow absorption of the specimens, characterised in that said fibre (17) covers the tip (16) in the form of a layer deposited by flocking whereby the layer of flocked fibre is capable of absorbing and releasing substantially the same quantity of specimen.
Patent NZ-543300-A (NZ)
Title: Sealing gland with endless lip seal and compression flange
Inventor: HAYNES ANDREW LEO
Filed: 2005-10-27
Abstract: The disclosure relates to a peripheral sealing gland to form a seal, between an elongate member and a substantially flat surface. The gland has an at least in part tapered skirt or frustoconical shaped skirt through which the elongate member is to pass and defining at the upper periphery of the skirt and deformable upper seal to deform about and seal to a periphery of said elongate member. A flange depends from the lower periphery of the skirt including on its outward from the skirt presented surface, at least one endless lip to seal when brought into contact, against said substantially flat surface. A compression ring is able to bear on said flange, to be fastened to said substantially flat surface to capture the flange therebetween. In an alternative embodiment a planar flange with at least one endless lip seal is disclosed, and a further alternative embodiment combines this with the frusto-conical shaped skirt.
Patent NZ-544909-A (NZ)
Title: System for packaging and labelling of sorted products
Inventor: DAVIDSON IVAN JOHN
IPC: B65B25/04
Filed: 2004-07-02
Abstract: A system for sorting and packaging of products includes sorting means including a plurality of sorting stations, recordal means including one or more processing units and packaging means for packaging one or more of the products to produce a packaging unit. Each of the processing units includes a processor operatively associated with one or more of the sorting stations and a labelling means operatively associated with the processor. The processor records information in one or more predetermined fields relevant to the products being sorted. In use the products are sorted and a single label is then produced by the recordal means and applied to the packaging unit. The label includes at least part of the information and is printed in a human readable format, electronic readable format or both human and electronic readable formats. The single label is used as the sole indicator for tracking and further processing purposes.
Patent NZ-552031-A (NZ)
Title: Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
Inventor: MALAMAS MICHAEL SOTIRIOS
IPC: C07D403/10
Filed: 2005-06-14
Abstract: Disclosed is a compound of formula (I) and the use thereof for the therapeutic treatment, prevention or amelioration of a disease or disorder characterized by elevated ss-amyloid deposits or ss-amyloid levels in a patient.